About This Fund
ARCH Venture Fund VIII is an early-stage venture capital fund managed by ARCH Venture Partners, focused on disruptive biotechnology, life sciences, energy, and materials companies. The fund closed above $400 million in August 2014, significantly exceeding its $250 million target. ARCH Venture Partners specializes in commercializing breakthrough technologies developed at academic institutions, national laboratories, and corporate research groups, co-founding companies alongside leading scientists and entrepreneurs.